NCT07800442Completed
Effect of Fish-Derived Lipids in Women With Endometriosis
Effect of Fish-Derived Lipids on Inflammatory Status, Nutritional Status, Pain Perception, Health-Related Quality of Life, and Health Outcomes in Women With Endometriosis
Source: ClinicalTrials.gov · Last updated 2 Sept 2026
Brief summary (registry, in English)
Endometriosis is a chronic inflammatory gynecological disease that may be associated with pelvic pain, painful menstruation, reduced quality of life, impaired daily functioning, and changes in nutritional and metabolic health. Diet, particularly the type and amount of dietary fatty acids, may influence inflammatory pathways involved in endometriosis. The purpose of this interventional study is to evaluate the effect of a 12-week nutritional intervention using BioMarine® Medical Immuno \& Neuro Lipids, a food for special medical purposes containing fish-derived lipids, on nutritional status, inflammatory status, lipid profile, pain perception, health status, and health-related quality of life in women with endometriosis. The study includes 50 women aged 18 to 40 years with endometriosis confirmed by a gynecologist. Participants are randomly assigned to one of two groups. The control group follows a balanced diet based on the Polish Healthy Eating Plate recommendations. The intervention group follows the same dietary recommendations and additionally consumes BioMarine® Medical Immuno \& Neuro Lipids at a dose of 0.5 ml/kg body weight daily for 12 weeks. The study assesses dietary habits, nutritional knowledge, dietary intake, anthropometric measurements, body composition, lipid profile, selected inflammatory markers, calprotectin, pain intensity, and endometriosis-related quality of life. The results may help to better understand whether fish-derived lipids combined with dietary intervention can support symptom management and improve selected health outcomes in women with endometriosis.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 46 (actual)
- First submitted
- 11 Jun 2026
- Start date
- 1 Apr 2024
- Primary completion date
- 1 Jun 2025
- Lead sponsor
- Angelika Bogusz
- Diseases
- Endometriosis
- NCT number
- NCT07800442
What you commit to
- Study type: Interventional
- Participants enrolled: 46
- From 1 Apr 2024 to the primary completion date, 1 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous radiotherapy or chemotherapy.
Other illness
- Liver, kidney, or heart disease.
- Acute inflammatory conditions, including acute inflammation of the intestines, pancreas, liver, or gallbladder.
- Fish allergy or hypersensitivity to any component of the study product.
- Epilepsy.
- Implanted medical devices or materials, including pacemaker, defibrillator, stent, metal suture in the heart or blood vessel, or implants.
- Health condition requiring a specialist diet.
Other
- Pregnancy or lactation.
- Menopause or postmenopausal status.
- Current use of dietary supplements containing n-3, n-6, or n-9 fatty acids.
Who the study is looking for
- Female sex.
- Age \>18 years and \<55 years.
- Diagnosis of endometriosis confirmed by a gynecologist.
- Ability and willingness to provide written informed consent.
- Ability and willingness to comply with the study procedures, including dietary recommendation
Age in the registry: 18 years to 55 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Warsaw University of Life Sciences Coordinator of this site? Confirm its status | Warsaw | Poland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.